ImmunityBio, Inc. receives conditional EMA approval for Anktiva in NMIBC, following FDA and UK authorizations. IBRX faces formidable competition from JNJ’s Inlexzo, which demonstrates superior ...
Los Angeles, CA, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback